Top Pharmaceuticals stocks in United States
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $698.52bn | 66.31 | 0.64% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $359.25bn | 16 | 3.19% |
MRKMerck & Co | $322.99bn | 57.74 | 2.35% |
ABBVAbbvie | $290.01bn | 36.06 | 3.61% |
AMGNAmgen | $166.97bn | 40.68 | 2.78% |
PFEPfizer | $157.48bn | 9.92 | 5.93% |
CELG RTBristol-Myers Squibb Co | $89.17bn | 0.01 | 4358.49% |
BMYBristol-Myers Squibb Co | $89.17bn | 11.73 | 5.25% |
GILDGilead Sciences | $80.72bn | 11.61 | 4.66% |
ZTSZoetis | $76.23bn | 31.89 | 0.93% |
MCKMcKesson | $69.50bn | 23.5 | 0.42% |
BIIBBiogen | $31.67bn | 23.51 | n/a |
HZNPHorizon Therapeutics | $26.63bn | 51.44 | n/a |
CAHCardinal Health | $24.09bn | 18.71 | 2.02% |
RPRXRoyalty Pharma | $17.10bn | 11.21 | 2.82% |
BMRNBiomarin Pharmaceutical | $15.65bn | 78.12 | n/a |
VTRSViatris | $14.03bn | 21.94 | 4.07% |
INCYIncyte | $12.07bn | 15.93 | n/a |
CTLTCatalent | $10.23bn | n/a | n/a |